靶向外显子组测序与果蝇模型揭示原发性卵巢功能不全的分子基础
该研究对41名25岁前发病的非综合征性原发性卵巢功能不全(POI)意大利女性行靶向全外显子组测序,并在60名POI患者中验证,结合果蝇模型进行功能研究。结果发现AFP、DMRT3、MOV10、FYN和MYC在两组患者中均显著富集,为POI强候选基因。果蝇模型支持MOV10和DMRT3直系同源物在雌性生育力中的保守作用。
要点
- 靶向WES联合CNV分析可有效识别POI新候选基因。
- AFP、DMRT3、MOV10、FYN和MYC在两队列中均显著富集。
- 果蝇模型支持MOV10和DMRT3直系同源物在雌性生育力中的保守作用。
核心结论
- 整合基因组、统计、比较和功能分析支持POI的高度异质性寡基因本质。
- 发现两类关键基因:参与减数分裂的基因和维护细胞存活的基因。
研究设计与样本
- 对41名25岁前发病的意大利非综合征性POI女性行靶向WES,覆盖542个RefSeq基因。
- 在60名POI患者(35名法国、25名美国)中验证,并进行病例对照负荷检验。
- 利用小鼠和果蝇进行比较分析,并对两个候选基因进行果蝇功能建模。
主要发现
- 意大利队列41名中30名检出59个基因的64个经验证单核苷酸变异/插入缺失。
- 负荷检验突出13个卵巢基因最显著富集,验证队列得到11个显著富集基因。
- AFP、DMRT3、MOV10、FYN和MYC在两个患者队列中均显著,被视为强候选基因。
- 果蝇模型支持MOV10(armitage)和DMRT3(dmrt93B)直系同源物在雌性生育力中的保守作用。
关键数值与推荐
- POI在40岁以下女性中发生率为1%。
- 靶向WES覆盖542个RefSeq基因,这些基因在生殖或卵巢过程中表达或发挥功能。
- 意大利队列数据存入ClinVar,登录号SCV001364312至SCV001364375。
临床怎么用
- 靶向WES联合CNV分析可用于POI候选基因的识别。
- AFP、DMRT3、MOV10、FYN和MYC可作为POI遗传检测的候选基因。
- 果蝇模型可支持候选基因在雌性生育力中保守作用的功能验证。
局限性
- 靶向WES仅检测候选基因,可能遗漏外显子组数据中的其他罕见变异。
- 多数散发病例因父母DNA不可用而无法追踪遗传来源。
- 可能纳入临床意义不确定的遗传变异,未必导致患者表型。
- 果蝇模型未来需要更多突变体或RNAi品系验证候选基因在POI中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can a targeted whole exome sequencing (WES) on a cohort of women showing a primary ovarian insufficiency (POI) phenotype at a young age, combined with a study of copy number variations, identify variants in candidate genes confirming their deleterious effect on ovarian function? SUMMARY ANSWER: This integrated approach has proved effective in identifying novel candidate genes unveiling mechanisms involved in POI pathogenesis. WHAT IS KNOWN ALREADY: POI, a condition occurring in 1% of women under 40 years of age, affects women's fertility leading to a premature loss of ovarian reserve. The genetic causes of POI are highly heterogeneous and several determinants contributing to its prominent oligogenic inheritance pattern still need to be elucidated. STUDY DESIGN, SIZE, DURATION: WES screening for pathogenic variants of 41 Italian women with non-syndromic primary and early secondary amenorrhoea occurring before age 25 was replicated on another 60 POI patients, including 35 French and 25 American women, to reveal statistically significant shared variants. PARTICIPANTS/MATERIALS, SETTING, METHODS: The Italian POI patients' DNA were processed by targeted WES including 542 RefSeq genes expressed or functioning during distinct reproductive or ovarian processes (e.g. DNA repair, meiosis, oocyte maturation, folliculogenesis and menopause). Extremely rare variants were filtered and selected by means of a Fisher Exact test using several publicly available datasets. A case-control Burden test was applied to highlight the most significant genes using two ad-hoc control female cohorts. To support the obtained data, the identified genes were screened on a novel cohort of 60 Caucasian POI patients and the same case-control analysis was carried out. Comparative analysis of the human identified genes was performed on mouse and Drosophila melanogaster by analysing the orthologous genes in their ovarian phenotype, and two of the selected genes were fruit fly modelled to explore their role in fertility. MAIN RESULTS AND THE ROLE OF CHANCE: The filtering steps applied to search for extremely rare pathogenic variants in the Italian cohort revealed 64 validated single-nucleotide variants/Indels in 59 genes in 30 out of 41 screened women. Burden test analysis highlighted 13 ovarian genes as being the most enriched and significant. To validate these findings, filtering steps and Burden analysis on the second cohort of Caucasian patients yielded 11 significantly enriched genes. Among them, AFP, DMRT3, MOV10, FYN and MYC were significant in both patient cohorts and hence were considered strong candidates for POI. Mouse and Drosophila comparative analysis evaluated a conserved role through the evolution of several candidates, and functional studies using a Drosophila model, when applicable, supported the conserved role of the MOV10 armitage and DMRT3 dmrt93B orthologues in female fertility. LARGE SCALE DATA: The datasets for the Italian cohort generated during the current study are publicly available at ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/): accession numbers SCV001364312 to SCV001364375. LIMITATIONS, REASONS FOR CAUTION: This is a targeted WES analysis hunting variants in candidate genes previously identified by different genomic approaches. For most of the investigated sporadic cases, we could not track the parental inheritance, due to unavailability of the parents' DNA samples; in addition, we might have overlooked additional rare variants in novel candidate POI genes extracted from the exome data. On the contrary, we might have considered some inherited variants whose clinical significance is uncertain and might not be causative for the patients' phenotype. Additionally, as regards the Drosophila model, it will be extremely important in the future to have more mutants or RNAi strains available for each candidate gene in order to validate their role in POI pathogenesis. WIDER IMPLICATIONS OF THE FINDINGS: The genomic, statistical, comparative and functional approaches integrated in our study convincingly support the extremely heterogeneous oligogenic nature of POI, and confirm the maintenance across the evolution of some key genes safeguarding fertility and successful reproduction. Two principal classes of genes were identified: (i) genes primarily involved in meiosis, namely in synaptonemal complex formation, asymmetric division and oocyte maturation and (ii) genes safeguarding cell maintenance (piRNA and DNA repair pathways). STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Italian Ministry of Health grants 'Ricerca Corrente' (08C621_2016 and 08C924_2019) provided to IRCCS Istituto Auxologico Italiano, and by 'Piano Sostegno alla Ricerca' (PSR2020_FINELLI_LINEA_B) provided by the University of Milan; M.P.B. was supported by Telethon-Italy (grant number GG14181). There are no conflicts of interest.
引用
- Bestetti I, Barbieri C, Sironi A, et al. Targeted whole exome sequencing and Drosophila modelling to unveil the molecular basis of primary ovarian insufficiency. Hum Reprod. 2021. PMID: 34480478. doi:10.1093/humrep/deab192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。